AbCellera Biologics Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
AbCellera Biologics Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2019 to 2023.
  • AbCellera Biologics Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $2.83M.
  • AbCellera Biologics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $10.4M.
  • AbCellera Biologics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.63M, a 58.1% increase from 2021.
  • AbCellera Biologics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$3.89M, a 101% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $10.4M +$12M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 -$1.63M +$2.26M +58.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 -$3.89M -$688M -101% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $684M +$683M +350491% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $195K Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.